Association between edaravone use and activities of daily living in older patients with atherothrombotic stroke: an observational study using Japanese real-world data

Abstract Background Edaravone is marketed in nine countries, although only Japan has approved edaravone for improvement of neurological symptom, disability of activities of daily living (ADL), and functional disability associated with acute stroke. This study aimed to elucidate the association of ed...

Full description

Bibliographic Details
Published in:BMC Geriatrics
Main Authors: Yukari Ogawa, Hiroko Akiyama, Takeshi Horii, Kiyoshi Mihara
Format: Article
Language:English
Published: BMC 2025-01-01
Subjects:
Online Access:https://doi.org/10.1186/s12877-024-05666-y